| URL | https://endpts.com/manufacturing-roundup-ajinomoto |
| Source | Endpoints News |
| Date Published | 04/20/2023 |
| Author Name | Tyler Patchen |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Ajinomoto Bio-Pharma Services |
| Parent company | Ajinomoto Co., Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2023 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | San Diego |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | fill finish lines, syringes |
| What domestic positive factors made reshoring more attractive? | Under-utilized capacity |